When colorectal cancer spreads to the liver, patients are often first told that surgery "isn't possible right now." This does not mean nothing can be done. It usually means that, given the current number, size, and location of the tumors—and how much healthy liver would remain after removal—it is not yet safe to operate.
Crucially, this assessment is not fixed forever. If chemotherapy shrinks the tumors enough, an operation that was once considered out of reach may become feasible. Treatment aimed at turning an "unresectable" situation into a "resectable" one is called conversion therapy. The idea is to reduce the tumor burden (downsizing) so that surgery becomes an option again.
Whether surgery is possible depends on several factors, not a single number: whether enough functioning liver would remain after removal (future liver remnant), whether tumors involve major blood vessels, and whether the person is well enough for a major operation. These decisions are usually made by a multidisciplinary team, which is why the same scans can be judged differently at different hospitals or at different points in time.
Response to treatment is mainly judged by imaging such as CT scans, which show changes in tumor size and number. Tumor markers like CEA and CA19-9 add useful context, but a single value falling sharply does not confirm a cure, and a small rise does not confirm failure. Trends over time, read alongside imaging, matter more than any one figure. It is also worth knowing that mild side effects do not mean a drug is failing—the intensity of side effects and the effectiveness of treatment vary from person to person and are not proportional.
Sometimes the primary bowel tumor and the liver metastases are removed in a single operation (simultaneous resection); in other cases surgery is staged over time. The best approach depends on tumor location, the extent of surgery, and the person's ability to recover. And even a successful operation does not always mean "cured." Microscopic cancer cells may remain, so adjuvant chemotherapy and regular follow-up scans usually continue afterward.
Feeling anxious even after good news is completely normal. Fear of recurrence and tension before each scan are shared by many people. If these feelings disrupt sleep or weigh heavily on daily life, that too can be discussed with your care team as part of treatment.
This article is general information and does not replace personal medical care. Please discuss your own stage, condition, and treatment plan with your own healthcare team.